<code id='C66C2908DA'></code><style id='C66C2908DA'></style>
    • <acronym id='C66C2908DA'></acronym>
      <center id='C66C2908DA'><center id='C66C2908DA'><tfoot id='C66C2908DA'></tfoot></center><abbr id='C66C2908DA'><dir id='C66C2908DA'><tfoot id='C66C2908DA'></tfoot><noframes id='C66C2908DA'>

    • <optgroup id='C66C2908DA'><strike id='C66C2908DA'><sup id='C66C2908DA'></sup></strike><code id='C66C2908DA'></code></optgroup>
        1. <b id='C66C2908DA'><label id='C66C2908DA'><select id='C66C2908DA'><dt id='C66C2908DA'><span id='C66C2908DA'></span></dt></select></label></b><u id='C66C2908DA'></u>
          <i id='C66C2908DA'><strike id='C66C2908DA'><tt id='C66C2908DA'><pre id='C66C2908DA'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:fashion    Page View:462
          Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT
          Adobe

          For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

          But don’t take their numbers as gospel, experts warned.

          advertisement

          “It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology
          JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

          FogPharmaCEOMathaiMammenVenrockSANFRANCISCO—SixmonthsintohistenureasCEOofcancerstartupFogPharma,Math

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

          Whatmakesablockbuster?CanbiotechlearnfromAduhelm?Andhowdoyoureplaceasingularregulator?Wecoverallthat